Search - tctmd.com

Displaying 1 - 20 of 45

Sort: Relevancy | Date

News Industry News

Pi-Cardia Reports First Commercial Cases with ShortCut™

March 03, 2025

Presentation AHA 2024

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

Presenter: Chisato Izumi

November 17, 2024

News Conference News AHA 2024

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Yael L. Maxwell

November 17, 2024

News Industry News

Pi-Cardia Receives FDA Market Clearance for ShortCut™

October 01, 2024

News Conference News NY Valves 2024

Long-term Mortality After TAVI Lower With DOACs vs VKAs

Todd Neale

June 06, 2024

News Conference News EuroPCR 2024

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

Shelley Wood

May 16, 2024

News Daily News

Left-Sided Bioprosthetic Valves Often Dysfunctional in Pregnant Women

L.A. McKeown

November 21, 2022

News Daily News

Ross Procedure Again Surpasses Bioprosthetic AVR: Toronto Experience

Caitlin E. Cox

March 08, 2022

News Daily News

Better 15-Year Survival With Ross Procedure Than Bioprosthetic AVR

Caitlin E. Cox

February 22, 2022

News Opinion CV Team Dispatch

July/August 2021 News Roundup

L.A. McKeown

August 01, 2021

News Daily News

Be ‘Mindful’ of TAVI Unknowns in Younger Patients, Experts Urge

Caitlin E. Cox

June 09, 2021

News Daily News

DOACs Safe, Effective in Subset of Valvular AF Patients

Shelley Wood

March 31, 2021

News Conference News CRT 2021

DOAC Use Increasing in Patients With Bioprosthetic Heart Valves

Todd Neale

March 08, 2021

News Daily News

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

Caitlin E. Cox

December 23, 2020

News Conference News TVT 2020

Device Explants After TAVR Rare but Risky

Michael O'Riordan

June 24, 2020

News Daily News

SAVR After Failed TAVR: Rare and Risky, Registry Study Finds

Yael L. Maxwell

June 10, 2020

News Daily News

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Yael L. Maxwell

February 28, 2020

News Conference News STS 2020

For Congenital Heart Disease, SAVR With Bioprosthetic Valve Still Reigns

Yael L. Maxwell

January 30, 2020

News Daily News

Contentious Medical Device Tax May Soon Be Gone for Good

Yael L. Maxwell

December 20, 2019

Presentation CIT 2019

TAVR for Failed Aortic Bioprosthetic Surgical Valves: Clinical Overview

Presenter: David Zhao

March 28, 2019

Advertisement

Pi-Cardia Reports First Commercial Cases with ShortCut™

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Pi-Cardia Receives FDA Market Clearance for ShortCut™

Long-term Mortality After TAVI Lower With DOACs vs VKAs

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

Left-Sided Bioprosthetic Valves Often Dysfunctional in Pregnant Women

Ross Procedure Again Surpasses Bioprosthetic AVR: Toronto Experience

Better 15-Year Survival With Ross Procedure Than Bioprosthetic AVR

July/August 2021 News Roundup

Be ‘Mindful’ of TAVI Unknowns in Younger Patients, Experts Urge

DOACs Safe, Effective in Subset of Valvular AF Patients

DOAC Use Increasing in Patients With Bioprosthetic Heart Valves

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

Device Explants After TAVR Rare but Risky

SAVR After Failed TAVR: Rare and Risky, Registry Study Finds

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

For Congenital Heart Disease, SAVR With Bioprosthetic Valve Still Reigns

Contentious Medical Device Tax May Soon Be Gone for Good

TAVR for Failed Aortic Bioprosthetic Surgical Valves: Clinical Overview

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content